1. Home
  2. BEAM vs RNST Comparison

BEAM vs RNST Comparison

Compare BEAM & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • RNST
  • Stock Information
  • Founded
  • BEAM 2017
  • RNST 1904
  • Country
  • BEAM United States
  • RNST United States
  • Employees
  • BEAM N/A
  • RNST N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • RNST Major Banks
  • Sector
  • BEAM Health Care
  • RNST Finance
  • Exchange
  • BEAM Nasdaq
  • RNST Nasdaq
  • Market Cap
  • BEAM 1.9B
  • RNST 1.8B
  • IPO Year
  • BEAM 2020
  • RNST N/A
  • Fundamental
  • Price
  • BEAM $24.70
  • RNST $35.38
  • Analyst Decision
  • BEAM Buy
  • RNST Buy
  • Analyst Count
  • BEAM 10
  • RNST 5
  • Target Price
  • BEAM $47.67
  • RNST $40.75
  • AVG Volume (30 Days)
  • BEAM 1.1M
  • RNST 556.1K
  • Earning Date
  • BEAM 02-25-2025
  • RNST 01-21-2025
  • Dividend Yield
  • BEAM N/A
  • RNST 2.47%
  • EPS Growth
  • BEAM N/A
  • RNST 6.89
  • EPS
  • BEAM N/A
  • RNST 3.09
  • Revenue
  • BEAM $349,643,000.00
  • RNST $685,874,000.00
  • Revenue This Year
  • BEAM N/A
  • RNST N/A
  • Revenue Next Year
  • BEAM $10.82
  • RNST $36.82
  • P/E Ratio
  • BEAM N/A
  • RNST $11.57
  • Revenue Growth
  • BEAM 328.73
  • RNST 8.24
  • 52 Week Low
  • BEAM $20.84
  • RNST $27.98
  • 52 Week High
  • BEAM $49.50
  • RNST $39.47
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 41.30
  • RNST 43.52
  • Support Level
  • BEAM $24.96
  • RNST $34.03
  • Resistance Level
  • BEAM $29.52
  • RNST $36.39
  • Average True Range (ATR)
  • BEAM 1.64
  • RNST 1.03
  • MACD
  • BEAM -0.51
  • RNST -0.11
  • Stochastic Oscillator
  • BEAM 9.71
  • RNST 36.59

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.

Share on Social Networks: